Chris Denn is a partner in the firm's Business Law Department and member of its Life Sciences Practice.

Mr. Denn assists boards of directors and management teams in navigating the wide variety of commercial and legal issues that are critical to the success or failure of a company’s efforts to deliver new treatments to patients.

Mr. Denn has a sophisticated understanding of the life science industry informed by years spent as an in-house lawyer at AstraZeneca and extensive experience in private practice advising clients ranging from start-up companies to mid-cap public companies.

Mr. Denn advises on corporate governance and finance matters, mergers and acquisitions, strategic collaborations, commercial transactions and dispute resolution. Mr. Denn also provides guidance on integrating advice from other legal experts, such as patent prosecutors, litigators and tax advisors, so that it aligns with corporate strategy and practices.